Sean Ash joined Maxim Group in 2008 and serves as Managing Director of the Merchant Capital Division. In this role, he is responsible for identifying opportunities and raising capital for private biotechnology companies seeking to develop novel therapeutics. Since 2008, Sean has participated in financings totaling over $1 billion. In addition to raising capital and building portfolios in the alternative investment space, Sean leverages his deep network of former CEOs, heads of research and biotechnology entrepreneurs to help assemble the boards and management teams that govern the group’s portfolio companies. He became a partner of the firm in 2017 and maintains Series 7, 63, and 65 FINRA licenses.
Prior to joining Maxim Group, Sean worked as a Senior Business Banking Consultant at Washington Mutual, now JP Morgan Chase.
Sean earned a degree in finance from Hofstra University, Zarb School of Business.
